RxDoctor Payments Data

Tae Hwan Chung, MD

Physical Medicine & Rehabilitation · Baltimore, MDNPI 1447420468

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (46.2%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 5 manufacturers reported payments, led by CSL Behring at 35.6% of the total. Reporting peaked in 2024 at $2,357 and has fallen 95.6% since, to $104 in 2025.

$3,345in general payments, 2019–2025

Across 19 payments — averaging $176.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • CSL Behring$1K
  • Regeneron$1K
  • Argenx US, Inc.$803
  • Medtronic$104
  • Grifols USA, LLC$81
$977,924in research payments, 2019–2025

Across 314 payments — averaging $3114.41 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Argenx US, Inc.$976K
  • Regeneron$2K

What the payments were for

  • Consulting fees$1,16835%
  • Travel & lodging$1,54646%
  • Food & beverage$63019%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
CSL Behring6$1,189
Regeneron2$1,168
Argenx US, Inc.9$803
Medtronic1$104
Grifols USA, LLC1$81

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,345 in reported general payments places this provider in the 85th percentile of 202 physical medicine & rehabilitation providers in Maryland.

See all physical medicine & rehabilitation providers in Maryland

Medicare billing

Part B allowed, 2024
$21,355
Medicare patients
150
Services billed
245

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
PanzygaImmun Glob G(Igg)-Ifas/Glycine14$519,675
Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov5012$360,329
Midodrine Hcl22$2,090

Paid to pharmacies, not to this prescriber.

Other physical medicine & rehabilitation in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →